Towards Longitudinal Glioma Segmentation: Evaluating combined pre- and post-treatment MRI training data for automated tumor segmentation using nnU-Net.
Glioma Segmentation
MRI
post-treatment
Journal
medRxiv : the preprint server for health sciences
Titre abrégé: medRxiv
Pays: United States
ID NLM: 101767986
Informations de publication
Date de publication:
05 Jun 2023
05 Jun 2023
Historique:
pubmed:
19
6
2023
medline:
19
6
2023
entrez:
19
6
2023
Statut:
epublish
Résumé
Identification of key phenotypic regions such as necrosis, contrast enhancement, and edema on magnetic resonance imaging (MRI) is important for understanding disease evolution and treatment response in patients with glioma. Manual delineation is time intensive and not feasible for a clinical workflow. Automating phenotypic region segmentation overcomes many issues with manual segmentation, however, current glioma segmentation datasets focus on pre-treatment, diagnostic scans, where treatment effects and surgical cavities are not present. Thus, existing automatic segmentation models are not applicable to post-treatment imaging that is used for longitudinal evaluation of care. Here, we present a comparison of three-dimensional convolutional neural networks (nnU-Net architecture) trained on large temporally defined pre-treatment, post-treatment, and mixed cohorts. We used a total of 1563 imaging timepoints from 854 patients curated from 13 different institutions as well as diverse public data sets to understand the capabilities and limitations of automatic segmentation on glioma images with different phenotypic and treatment appearance. We assessed the performance of models using Dice coefficients on test cases from each group comparing predictions with manual segmentations generated by trained technicians. We demonstrate that training a combined model can be as effective as models trained on just one temporal group. The results highlight the importance of a diverse training set, that includes images from the course of disease and with effects from treatment, in the creation of a model that can accurately segment glioma MRIs at multiple treatment time points.
Identifiants
pubmed: 37333148
doi: 10.1101/2023.05.31.23290537
pmc: PMC10274985
pii:
doi:
Types de publication
Preprint
Langues
eng
Subventions
Organisme : NCI NIH HHS
ID : R01 CA164371
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS060752
Pays : United States
Organisme : NCI NIH HHS
ID : U54 CA143970
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA250481
Pays : United States
Organisme : NCI NIH HHS
ID : U54 CA210180
Pays : United States
Organisme : NCI NIH HHS
ID : U54 CA193489
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA220378
Pays : United States